XML 127 R111.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information (Tabulation of Business Segment Information Based on Current Segmentation) (Details) - USD ($)
 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Segment Reporting Information [Line Items]      
Total Consolidated Revenue $ 1,450,826,000 $ 1,381,842,000 $ 899,248,000
Total consolidated adjusted operating income 287,570,000 267,602,000 148,861,000
Deferred revenue adjustment   (8,561,000)  
CEO transition costs   (6,195,000)  
Restructuring expense (18,817,000) (25,628,000) (6,869,000)
Business acquisition and integration expense (42,661,000) (53,198,000) (31,593,000)
Litigation settlement expense (10,000,000)    
Gain on sale of assets 13,317,000 0 0
Total consolidated operating income 168,170,000 76,746,000 110,399,000
Interest expense (63,100,000) (129,348,000) (41,365,000)
Other income, net 6,965,000 1,108,000 6,732,000
Total consolidated income (loss) from continuing operations before income taxes 112,035,000 (51,494,000) 75,766,000
Total Consolidated capital expenditures 37,008,000 31,054,000 39,881,000
Total consolidated depreciation expense 41,575,000 44,574,000 33,888,000
Total consolidated intangible amortization expense (61,239,000) (97,274,000) 0
Chamberlain      
Segment Reporting Information [Line Items]      
Total Consolidated Revenue 571,034,000 557,536,000 563,814,000
Walden University      
Segment Reporting Information [Line Items]      
Total Consolidated Revenue 533,725,000 485,393,000 0
Medical and Veterinary      
Segment Reporting Information [Line Items]      
Total Consolidated Revenue 346,067,000 338,913,000 335,434,000
Operating Segments [Member] | Chamberlain      
Segment Reporting Information [Line Items]      
Total Consolidated Revenue 571,034,000 557,536,000 563,814,000
Total consolidated adjusted operating income 135,503,000 127,252,000 128,851,000
Total Consolidated capital expenditures 17,749,000 15,235,000 28,631,000
Total consolidated depreciation expense 17,264,000 18,547,000 16,123,000
Operating Segments [Member] | Walden University      
Segment Reporting Information [Line Items]      
Total Consolidated Revenue 533,725,000 485,393,000  
Total consolidated adjusted operating income 110,364,000 104,582,000  
Total Consolidated capital expenditures 4,688,000 5,393,000  
Total consolidated depreciation expense 9,492,000 9,255,000  
Total consolidated intangible amortization expense (61,239,000) (97,274,000)  
Operating Segments [Member] | Medical and Veterinary      
Segment Reporting Information [Line Items]      
Total Consolidated Revenue 346,067,000 338,913,000 335,434,000
Total consolidated adjusted operating income 67,336,000 69,148,000 60,199,000
Restructuring expense (7,687,000) (9,791,000)  
Total Consolidated capital expenditures 4,386,000 3,277,000 4,121,000
Total consolidated depreciation expense 12,475,000 13,890,000 14,431,000
Corporate, Non-Segment [Member]      
Segment Reporting Information [Line Items]      
Total consolidated adjusted operating income (25,633,000) (33,380,000) (40,189,000)
Restructuring expense (7,067,000) (8,946,000) (6,869,000)
Total Consolidated capital expenditures 10,185,000 7,149,000 7,129,000
Total consolidated depreciation expense $ 2,344,000 $ 2,882,000 $ 3,334,000